Protagonist Therapeutics, Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 144.85 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 9.37B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Protagonist Therapeutics, Inc. operates as a discovery and development company in the United States. It develops Icotyde, a first-in-class investigational targeted oral peptide for the treatment of adults and pediatric patients 12 years of age and older with moderate-to-severe plaque psoriasis; and Rusfertide, a first-in-class investigational injectable mimetic of the natural hormone hepcidin in Phase 3 development for the treatment of the rare blood disorder polycythemia vera. The company is also developing PN-881, a potential best-in-class oral peptide IL-17 antagonist, for the treatment of immune-mediated skin diseases in Phase 1 clinical trials; PN-477 and PN-458, which are development candidates for the treatment of obesity; PN-8047, an orally administered hepcidin functional mimetic small molecule; L-4R alpha antagonist for the treatment of atopic dermatitis and moderate-to-severe asthma; and amylinR-based oral and subcutaneous mono- and poly-agonists for the treatment of obesity. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.
Details
| Name | Protagonist Therapeutics, Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 141 |
| Founded | 2006 |
| Ipo Date | 2016-08-11 |
| Ceo | Dinesh Patel |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Isin | US74366E1029 |
| Cusip | 74366E102 |
| Cik | 0001377121 |
| Sic | 2834 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Dr. Dinesh V. Patel Ph.D. | Chief Executive Officer, President, Secretary and Director |
| Asif Ali | Executive Vice President and Chief Financial Officer |
| Dr. Arturo M. Molina FACP, M.D., M.S. | Chief Medical Officer |
| Venkat Thalladi Ph.D. | Executive Vice President and Chief Technical Officer |
| Dr. Newman Yeilding M.D. | Executive Vice President, Chief Scientific Officer |
| Matthew M. Gosling J.D. | Executive Vice President and Chief Legal and Business Officer |
| Carena Spivey | Executive Vice President and Chief Human Resources Officer |
| Dr. Ashok Bhandari Ph.D. | Executive Vice President and Chief Discovery Officer |
| Carter J. King | Executive Vice President of Business Development |
| Abha Bommireddi | Executive Vice President and Chief of Staff |
Contact
| Address | 7707 Gateway Boulevard, Suite 140, Newark, California 94560, United States |
| Phone | 510 474 0170 |
| Website | https://www.protagonist-inc.com |